The solution to this is regulatory exclusivity. The big cost is going through the FDA process, companies could simply be granted a 15 year exclusivity once they

The solution to this is regulatory exclusivity. The big cost is going through the FDA process, companies could simply be granted a 15 year exclusivity once they've passed that bar. The FDA already has a process setup for granting this.